Elevance Health, Inc. (ELV)
Elevance Health, Inc. (ELV), formerly known as Anthem, Inc., is a leading health benefits company that provides a range of health insurance products and services. Based in the United States, it offers medical, dental, vision, and pharmacy plans, as well as related administrative services. The company serves individuals, employers, and government programs, and is recognized for its commitment to improving health outcomes and innovative healthcare solutions.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 25, 2025 | $1.71 | 2025-09-10 | 2025-09-10 |
| June 25, 2025 | $1.71 | 2025-06-10 | 2025-06-10 |
| March 25, 2025 | $1.71 | 2025-03-10 | 2025-03-10 |
| December 20, 2024 | $1.63 | 2024-12-05 | 2024-12-05 |
| September 25, 2024 | $1.63 | 2024-09-10 | 2024-09-10 |
Dividends Summary
- Elevance Health, Inc. has issued 67 dividend payments over the past 18 years
- The most recent dividend was paid 27 days ago, on September 25, 2025
- The highest dividend payed out to investors during this period was $1.71 per share
- The average dividend paid during this period was $0.82 per share.
Company News
Elevance Health reported Q3 2025 operating revenue of $50.1 billion, a 12% increase from 2024, with diluted EPS of $5.32. The company maintained full-year guidance despite challenges in Medicaid membership and increased medical costs.
Humana lost a legal challenge against federal government cuts to its Medicare Advantage bonus payments, with a Texas judge upholding the downgrade of its star ratings. This ruling could potentially impact billions in revenue for the company.
Grabar Law Office is investigating potential securities fraud and fiduciary duty breaches for several companies, including Elevance Health, Humana, Maison Solutions, and Vestis Corp, alleging misleading financial statements and undisclosed material risks.
Billionaire investors bought shares of five safe stocks before the recent market volatility, including Philip Morris International, Teva Pharmaceutical, Sirius XM, Elevance Health, and American Tower. These stocks are seen as defensive and able to withstand market turbulence.
Elevance Health reported strong Q2 2024 earnings, with adjusted EPS of $10.12 beating estimates. However, the company saw a decline in medical membership and premium revenues, impacting overall margins. The results were driven by improved product revenues in the CarelonRx business and higher net investment income.
